Patent ID: 7482433

Claim:
A method for treating a patient having a condition mediated by IL-5 comprising administering to the patient a therapeutically effective amount of a compound that effects homodimerization of the alpha chain of the IL-5 receptor, wherein said compound comprises a member selected from the group of peptides consisting of: TGGGDGYV X 3 VE X 4 ARCPTCK; (residues 32-50 of SEQ ID NO:1) EGYV X 3 VE X 4 ARCPTCK; (residues 36-50 of SEQ ID NO:2) EGYV X 3 VE X 4 ARCPTCR; (residues 36-50 of SEQ ID NO:3) GYV X 3 VE X 4 ARCPTCG; (residues 36-50 of SEQ ID NO:4) EGYV X 3 VE X 4 ARCPTCG; (residues 36-50 of SEQ ID NO:5) GYV X 3 VE X 4 ARCPTCR; (residues 37-50 of SEQ ID NO:6) and EGYV X 3 VE X 4 AACPTCR (residues 36-50 of SEQ ID NO:7) wherein X 3 is Cys, Lys, or Dpr, and X 4 is Nal, Trp, or Phe.